Falang Database driver not enabled

CapDecisif Management announces the first closing of new fund CapDecisif 4

cap.decisif4CapDecisif Management announces the first closing of CapDecisif 4. Targeting 50m€, this new fund focuses on Digital Health as well as Digital and Healthcare ventures, three areas in which our team has demonstrated recurring significant returns. CapDecisif 4 will invest at seed stage in innovative companies leading or co-leading the first institutional financing round, with a strong capacity for follow-on investments.

 
Leveraging our Digital and Healthcare expertise

CapDecisif 4’s main investor is Bpifrance via the Fonds National d’Amorçage 1 in the framework of the Programme d’investissements d’avenir (PIA). Other financial investors participating to this first closing include historical partners BNP Paribas and Caisse d’Epargne Ile-de-France, as well as family offices, including Pradeyrol Developpement, and entrepreneurs, who entrust the CapDecisif Management team with close relationships built on common business cases for years.

logos

A Multi-Corporate fund with focus on Digital Health

To address the opportunity of Digital Health a Multi-Corporate approach has been established in order to partner with key operators of the Wellbeing and Healthcare value chain. This sector is now starting its digital transformation powered by the surge of new technologies such as Artificial Intelligence being applied to healthcare, and the emergence of proven business models with healthcare payors and business development alliances with industry majors.
 
Cornerstone corporate investors in CapDecisif 4’s first closing include Well-being and Healthcare leaders:

  • Philips (NYSE: PHG, AEX: PHIA), global leader in health technology, investing through its  Health Technology Ventures Fund, with a strong relationship built with Philips France, a leading market for Philips in Digital Health and Artificial Intelligence.
  • The cosmetic group L’Occitane via its start-up studio OBRATORI (or L’Occitane Innovation LAB) based in Marseille incubates and accelerates innovative companies or start-ups arising from leading academic research of cosmetics, healthcare and well-being.
  • Vivalto, family office of Mr Daniel Caille, President of Vivalto Santé, 3rd group of private hospitalization in France, a key opinion leader in the field of private hospitalization, and investor in various companies of the healthcare value chain such as nursing homes or home care companies.
     

E-Health 360°, a Digital Health Think-Tank dedicated to the Fund and its portfolio

These corporates, joined by leading experts and public institutions, are contributing to E-Health 360°, a CapDecisif 4 dedicated Think-Tank aimed at reviewing investment opportunities ensuring a common vision that the solutions proposed fit the sector’s digital transformation, as well as offering portfolio companies mentoring to accelerate their growth with partnerships expected to arise.
Other corporate partners are expected to join the Think Tank along their commitment to the fund.

rep fr